Industry News Roundup
This article was originally published in The Tan Sheet
Executive Summary
Prestige international sales jump; P&G settles Whitestrips infringement case; BlueOcean targets Indian omega-3 market; ViaDerma shop its dual carrier transdermal delivery; unapproved drugs make prostate, rosacea claims; and more industry news.
You may also be interested in...
Aussie Regulator ID’s Underpreserved Cosmetics As Adverse-Event Contributor
Australia’s Competition and Consumer Commission says that 30% of all consumer product injury reports it received in the past year were associated with cosmetics, which it partially attributes to inadequate product preservation. In addition to promoting good manufacturing practices, the ACCC will be surveying cosmetic product labeling on a continuing basis.
In Brief: Prestige Buys Insight, Quarterly Earnings For MJN And Colgate, Bio-Recovery Warned On Claims
Prestige acquires Insight Pharmaceuticals; Product relaunches boost Novartis’ consumer sales; Colgate’s N.A. sales inch up; Mead Johnson sales up 7%; and Bio-Recovery makes drug claims.
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.